Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Purchase of 10,000 NAMS shares, $226.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Purchase | 10,000 | $226.5K |
| Jun 12, 2026 | BioAge Labs, Inc. (BIOA) | Grant/Award | 22,000 | n/a |
| Mar 2, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Exercise/Conversion | 443,707 | n/a |
| Feb 27, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Exercise/Conversion | 64,708 | n/a |
| Jan 14, 2026 | TENAX THERAPEUTICS, INC. (TENX) | Grant/Award | 30,000 | n/a |
| Jan 10, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Sale | 11,582 | n/a |
| Jul 3, 2025 | TENAX THERAPEUTICS, INC. (TENX) | Grant/Award | 80,000 | n/a |
| Jun 9, 2025 | BioAge Labs, Inc. (BIOA) | Grant/Award | 22,000 | n/a |
| Mar 28, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 30,992 | n/a |
| Jan 7, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 123,529 | n/a |